588 / 1609
Outcome
Systematic Review
Peinemann et al. Eur Urol 2011;60:881-893
Most studies T1-T2
Majority Gleason <7 and PSA < 10 ng/ml
(20-30% PSA ≥10 ng/ml)
5 year OS: 71-96%
|
|
588 / 1609
Outcome
Systematic Review
Peinemann et al. Eur Urol 2011;60:881-893
Most studies T1-T2
Majority Gleason <7 and PSA < 10 ng/ml
(20-30% PSA ≥10 ng/ml)
5 year OS: 71-96%